A unique, recently described rat alveolar macrophage cell line (NR8383) was used to study the interaction of the pulmonary immune system with a mucoid cystic fibrosis isolate of Pseudomonas aeruginosa (SRM-3), its nonmucoid revertant (SRM-3R), and a non-cystic fibrosis isolate (PAO-1). Strain SRM-3 was cultivated in a chemostat system to allow maintenance of an entirely mucoid population. The alveolar macrophage response to the mucoid and nonmucoid strains of P. aeruginosa was determined by visually quantitating phagocytosis in acridine orange-stained monolayers and measuring the induction of an oxidative burst as indicated by chemiluminescence and H202 production. In all experiments, fewer than 2% of the NR8383 cells engulfed the mucoid SRM-3 isolate, while SRM-3R and PAO-1 were phagocytized by 15 and 41%, respectively. Opsonization by normal serum (complement) provided minimal phagocytic enhancement of these strains, whereas specific anti-P. aeruginosa antibody slightly elevated phagocytic responses to strains with nonmucoid phenotypes while providing a sevenfold increase in uptake of SRM-3. Chemiluminescent and H202 responses were comparable with the levels of phagocytosis observed, with very little or no response to the mucoid strain SRM-3. The data indicate that the strains with mucoid phenotypes are refractile to ingestion and that studies which describe ingestion of mucoid strains were likely measuring ingestion of revertants. Alginic acid (2 mg/ ml) was found to inhibit stimulation of macrophage response to the opsonized and unopsonized nonmucoid strain PAO-l.
Mucoid Pseudomonas aeruginosa is singularly responsible for the morbidity and mortality resulting from the chronic respiratory infection seen in the lungs of cystic fibrosis patients (11, 48) . Despite the evocation of an apparently intact immune response (12, 37) and the implementation of a heroic antibiotic regimen, once established this organism is virtually impossible to eradicate. The emergence of the mucoid form of this organism is invariably associated with a poor prognosis for the patient (24, 39) and usually occurs after initial colonization with nonmucoid P. aeruginosa as a result of a variety of host selective factors. Protective immunity against P. aeruginosa is thought to be achieved through phagocytic killing by peripheral polymorphonuclear neutrophils (PMN) and resident or elicited alveolar macrophages (AM) (1, 12) . However, there has been considerable controversy as to the ability of these host cells to ingest and kill mucoid P. aeruginosa. Several investigators have demonstrated that mucoid strains are more resistant to phagocytosis than nonmucoid strains are (7, 17, 42) . Resistance of mucoid strains to phagocytosis by macrophages and PMN has been attributed to the alginic acid polysaccharide produced by these strains (3, 23, 38, 43) , although some investigators have reported no difference between phagocytosis of mucoid and nonmucoid strains (5, 6, 31) . The difficulty in assessing the susceptibility of P. aeruginosa strains of different phenotypes to phagocytosis is due in part to (i) the rapid reversion of the mucoid phenotype to the nonmucoid phenotype (18, 26) and (ii) in the variability of responses exhibited by freshly derived macrophages or PMN (7) .
Phagocytes normally respond to ingested microorganisms by releasing toxic oxygen metabolities, such as superoxide, hydrogen peroxide, singlet oxygen, and hydroxyl radicals (4, * Corresponding author. 25 ). Therefore, the virulence of microorganisms may depend upon either their innate resistance to the reactive products of oxidative metabolism, their production of scavengers which neutralize toxic metabolities, or their ability to induce a metabolic burst, enabling them to evade oxygen-dependent killing by phagocytes. The present study investigated the ability of a continuous alveolar macrophage cell line (22) to phagocytize opsonized and nonopsonized mucoid and nonmucoid strains of P. aeruginosa and measured the resulting oxidative burst. Unique to this study were the utilization of a previously described chemostat system for maintaining the mucoid phenotype in vitro (26) and the use of a homogeneous, alveolar macrophage cell system.
(Portions of these studies appeared as a poster presentation at the Annual Meeting of the American Society for Microbiology, Miami Beach, Fla., 8 to 13 May 1988.) MATERIALS AND METHODS Bacterial strains. P. aeruginosa PAO-1 was obtained from B. Iglewski, Department of Microbiology and Immunology, Oregon Health Sciences University, Portland. The nonmucoid strain DLP and the mucoid strain SRM-3 were isolated from the sputum of cystic fibrosis patients at Santa Rosa Children's Hospital, San Antonio, Tex. To maintain strain SRM-3 in a mucoid form, several colonies were removed from mucoid maintenance agar plates (MacConkey agar base modified by the addition of 50 g of glycerol per liter) (13) , suspended in 5% skim milk, and stored at -80°C. The nonmucoid revertant (SRM-3R) was obtained by growth of the mucoid strain in alginate-promoting (AP) medium (described below) at 37°C without aeration for 18 h followed by isolation of the nonmucoid organisms on mucoid maintenance agar plates. An isolated nonmucoid colony was subcultured again and stored as described for the mucoid strain.
Culture medium. A modification of the AP medium of Mian et al. (32) was used for growth of all strains of P. aeruginosa; this has been described in detail elsewhere (26) . The AP medium contained 100 mM monosodium glutamate, 100 mM gluconate, 7.5 mM NaH2PO4, 16.8 mM K2HPO4, and 10 mM MgSO4. The pH was adjusted to 7.0 with 1 M NaOH. The mucoid strain SRM-3 was grown in a chemostat system which allowed constant aeration of the culture at a rate of 0.5 liter/min, a rate needed to maintain an entirely mucoid population of bacterial cells. Nonmucoid strains of P. aeruginosa were grown in batch cultures under nonshaking conditions or on mucoid maintenance agar plates.
Exopolysaccharides. Preparation and characterization of the exopolysaccharides of the mucoid strain SRM-3 and the nonmucoid strains PAO-1 and SRM-3R have been previously described (26, 27) . The alginic acid polysaccharide in both the bacterial alginate preparation and commercial alginate was quantitated by the harmine assay for uronic acids and pentoses (45) with mannuronic acid as the standard. Lipopolysaccharide was extracted from whole cells by the method of Westphal and Jann (47) for use in enzyme-linked immunosorbent assays.
Macrophages. These studies involved a rat alveolar macrophage NR8383 clone, AgCl1x3A, which was sequentially selected three times from isolated soft agar microcolonies. This clone, which has been previously characterized (22) , grows continuously in Ham F12 medium with 15% fetal bovine serum, 100 ,g of penicillin per ml, and 100 U of streptomycin per ml.
Phagocytosis assays. The methods of d'Arcy Hart and Young (9) and Pantazis and Kniker (35) were modified to measure the phagocytic response of AM. Sterile 22-mm glass cover slips in petri dishes (35 by 10 mm) were seeded with 0.1 ml of complete medium containing 1 x 104 to 5 x 104 macrophages. After 30 to 60 min of attachment at 37°C, an additional 2 ml of Ham F12 containing 5% fetal bovine serum was added. Cultures were retained in a humidified incubator in 5% C02-95% air at 37°C for 24 h before challenge. P. aeruginosa cultures containing approximately 109 to 1010 CFU/ml were spectrophotometrically (at 530 nm) adjusted to 108 CFU/ml in Hanks balanced salt solution (HBSS) and further diluted in HBSS to obtain a AM/CFU ratio of 1:300 to 1:500.
Nutrient medium was aspirated from NR8383 cultures, which were then rinsed once with 2 ml of HBSS and inoculated with 1 ml of bacterial suspension. After 1 h at 37°C, inocula were removed and cells were rinsed with 2 ml of HBSS and stained with 6 pug of acridine orange per ml in HBSS for 3 min. After removal of the acridine orange, 2 H202 assays. Macrophages (5 x 105 cells) were exposed to stimuli (zymosan or bacterial suspensions) in the presence of homovanillic acid and horseradish peroxidase by using modifications of the methods of Ruch et al. (41) . After incubation at 37°C, reactions were terminated by the addition of glycine-NaOH buffer (pH 12), and relative fluorescence was monitored at an emission wavelength of 420 nm and an excitation wavelength of 312 nm on a fluorometer (System 3; Farrand, Valhalla, N.Y.). Alternatively, a Farrand Ratiofluorometer-2 was used with a 7-60 filter in the-primary mode and tandem 3-74 and 4-72 filters in the secondary mode. Each assay was extrapolated to standard dilutions of exogenous H202 under conditions identical to those of the experimental preparations.
CL assays. Chemiluminescence (CL) assays (21, 49) were performed with NR8383 (5 x 105 AM/ml) suspended in HBSS seeded in glass scintillation vials containing luminol (Sigma). Luminol stock (10 mg/ml) was dissolved in dimethyl sulfoxide (American Type Culture Collection, Rockville, Md.) and stored at -20°C. Subsequent dilutions were made in HBSS to a final concentration of 2.5 ,ug/ml. Stimuli (zymosan or bacterial suspensions) diluted in HBSS were added at time zero, and vials were read immediately and at intervals thereafter. All responses were recorded at ambient temperatures in a scintillation counter (LS150; Beckman Instruments, Inc., Fullerton, Calif.) in "out-of-coincidence" mode through a full window aperture. All studies were done with macrophage preparations which had been allowed to adhere in vials at 37°C for 2 to 3 h, precluding the possibility of spurious CL induced by adherence (R. J. Helmke, V. F. German, and J. A. Mangos, In Vitro Cell Develop. Biol., in press).
Human PMN assays. CL studies with human peripheral blood neutrophils were performed in a different laboratory under slightly different conditions than those described for assays involving NR8383 (V. L. Thomas et al., J. Immunol. Methods, in press). Just before being used in the neutrophil function test, all bacteria (prepared as described above) were pelleted by centrifugation at 5,000 x g for 15 min and suspended in phenol red-free HBSS to a concentration of 3 x 10' CFU/ml. Bacteria used in this assay were not opsonized. A 100-,ul volume of fresh whole blood was collected in glass capillary tubes, which were then incubated in a humidified chamber at 37°C under a 7% CO2 atmosphere for 60 min. Clots were removed and the remaining monolayer of phagocytic cells in each capillary tube (approximately 1 x 105 PMN) was rinsed and allowed to equilibrate in buffer for 10 ,ug/ml; zymosan, 0.1 mg/ml. which has been shown to be linked to the microbicidal activity of the macrophage. Microbicidal oxygen metabolites such as superoxide and hydrogen peroxide (25) were found to be produced in greater amounts when phagocytes interacted with microorganisms or other suitable stimuli. The sensitivity of the CL assay is markedly enhanced by the addition of luminol, which amplifies the amount of light produced and precludes the need for the cultures or vials in which they are assayed to be dark adapted. The ability of mucoid and nonmucoid strains of P. aeruginosa to elicit an oxidative CL response from NR8383 was examined (Table  1) . Zymosan was used as a positive control stimulus and produced a maximum CL response of 300 x 104 cpm. Unopsonized strains DLP and PAO-1 elicited lesser responses, with values of 112 x 104 cpm and 117 x 104 cpm, respectively. Unopsonized strains SRM-3 and SRM-3R induced very little response from NR8383, with the nonmucoid revertant eliciting only a slightly greater response than the mucoid parent strain. Opsonization of SRM-3 and SRM-3R resulted in approximately a fourfold increase in oxidative response, but even with opsonization, the mucoid strain SRM-3 triggered very little CL (49 x 104 cpm). The CL response to opsonized PAO-1 and DLP was approximately sixfold greater (288 x 104 and 254 x 104 cpm, respectively) than the response seen with opsonized SRM-3.
In order to determine whether the mucoid strain SRM-3 inhibited the ability of NR8383 to respond to any stimulus, we challenged the NR8383 cells with zymosan and SRM-3 simultaneously. The ability of NR8383 to respond to zymosan with an oxidative burst was not impaired by the presence of SRM-3 ( Table 1 ), indicating that the macrophages were capable of responding to a stimulus but could not significantly bind or respond to the mucoid strain of P. aeruginosa. Also shown are data indicating that the CL response was measuring an oxidative product of superoxide, since superoxide dismutase diminished CL by >90%. It should be pointed out that while there is a stoichiometric relationship between 02 and H202 produced under identical conditions (4) (Tables 1 and 2 ), our methods do not permit this extrapolation. The comparative levels of CL versus H202 production probably reflect the higher sensitivity of the luminolenhanced assay.
The kinetics of the CL response of NR8383 to mucoid and c In all cases, the mucoid strain was significantly less stimulatory (P < 0.01) than the nonmucoid strains were; comparison of unopsonized mucoid and revertant was not significant. d Mannose (3 mg/ml; Sigma) was added 30 min before stimulus (zymosan, 0.1 mg/ml).
nonmucoid strains of P. aeruginosa are shown in Fig. 2 . Opsonized PAO-1 elicited a response similar to that of zymosan, both inducing peak responses at 15 min. The response of NR8383 to unopsonized PAO-1 continued to increase during the 60-min period and approached levels equivalent to opsonized PAO-1 only after 60 min. Although NR8383 showed a slight response to opsonized SRM-3 at 5 min, there was essentially no significant response to either opsonized or unopsonized mucoid SRM-3.
Generation of H202 by NR8383 after challenge with P. aeruginosa. Generation of reactive oxygen intermediates by NR8383 was also demonstrated by H202 production ( Table  2) . NR8383 was again found to respond similarly to the nonmucoid strains PAO-1 and DLP, with the unopsonized strains resulting in generation of 2.7 and 3.7 nmol, and the opsonized strains stimulating production of 9.5 and 9.7 nmol, respectively. The nonmucoid revertant SRM-3R stimulated production of only 0.2 nmol and only slightly more, 1.4 nmol, when opsonized. The mucoid SRM-3 did not stimulate detectable levels of H202 by NR8383 even in the presence of opsonins. The addition of 3 mg of mannose per ml prior to stimulus produced little effect on H202 production in this system. Phagocytosis of mucoid and nonmucoid strains of P. aeruginosa by human neutrophils. In order to demonstrate that the inability of phagocytes to ingest and respond to mucoid SRM-3 was not unique to the alveolar macrophages, we performed phagocytosis and CL assays with human PMN. The induction of CL in PMN after challenge by strains PAO-1, SRM-3R, and SRM-3 was investigated (Fig. 3) . Strain PAO-1 readily evoked CL in PMN, with a peak activity of approximately 28,000 mean relative light units. The acridine orange fluorochrome assay revealed 100% of PMN associated with bacteria, and there appeared to be greater than 90% killing of ingested bacteria as evidenced by a well documented (9, 29, 35) orthochromatic color shift from green to red organisms. Strain SRM-3R, with a peak activity of 2,700, was not as effective at stimulating CL by the PMN, even though there was 100% association of PMN with the bacterial cells and greater than 90% killing. It is interesting to note that although the nonmucoid revertant SRM-3R was not as effective as PAO-1 in stimulating CL activity, the rate of uptake between the two organisms, PAO-1 and SRM-3R, was not significantly different as determined by the slope (not shown). Again, strain SRM-3 was not phagocytized by PMN. There was no CL activity, and no SRM-3 bacteria were found to be associated with PMN.
Inhibition of response with alginate. The effect of alginate on H202 production by NR8383 after stimulation with P. aeruginosa PAO-1 was determined by the addition of various concentrations of commercial seaweed alginate to bacteria before challenge (Table 3 ). In assays with opsonized bacteria, alginate was added to bacterial suspensions before and after opsonization with immune sera. Alginate (2 mg/ml) was also added to zymosan before challenge of NR8383. Alginate at a concentration of 2 mg/ml was found to inhibit H202 production by NR8383 when challenged with zymosan and unopsonized and opsonized PAO-1. However, the amount of inhibition observed did not correlate with the concentration of alginate during challenge of NR8383 with unopsonized PAO-1. Alginate at a concentration of 2 mglml resulted in 24% inhibition of H202 generation, while 0.5 mg of alginate per ml inhibited production by more than 50%. In assays with opsonized bacteria, H202 production was substantially inhibited by alginate at concentrations of 0.5 mg/ml or greater, but not in a dose-related fashion.
Alginate purified from strain SRM-3 was also tested to determine its effect on H202 production by NR8383 upon 1 h, 37°C ). e Alginate-treated, opsonized challenges were significantly (P < 0.001) inhibited relative to untreated opsonized challenges; unopsonized challenges were not significantly different.
challenge with unopsonized and opsonized PAO-1 (data not shown). The purified bacterial alginate at concentrations of 0.5 and 0.25 mg/ml nonspecifically fluoresced in the standard assay and in a cell-free system. In CL assays, similar concentrations of bacterial alginate inhibited luminol-enhanced CL by NR8383 80 to 95%; cell-free CL was also inhibited.
In order to determine whether the inhibition of an oxidative response to opsonized bacteria in the presence of commercial alginate was due to interference with the opsonization of the bacteria or interference with the response of macrophages to opsonized bacteria, the bacteria were treated with either 2 mg or 0.5 mg of alginate per ml before opsonization, after normal opsonization, or before and after opsonization with immune sera and then used for challenge of NR8383 in the H202 assay (Table 4) . Some inhibition of H202 response by NR8383 (19.4%) was observed after challenge with bacteria treated with 2 mg of alginate per ml during opsonization, but 0.5 mg of alginate per ml was not inhibitory. The response of NR8383 to opsonized strain PAO-1 was markedly inhibited by 2 and 0.5 mg of alginate per ml, whether it was present only during challenge or during both opsonization and challenge.
DISCUSSION
A comparison of the ability of NR8383 to phagocytize unopsonized mucoid and nonmucoid strains of P. aerugi- nosa revealed significant differences in the susceptibilities of the different strains. While the nonmucoid strains were readily phagocytized, the mucoid strain was not. These results are similar to those recently reported by Cabral et al. (7) . Interestingly, the nonmucoid revertant, SRM-3R, elicited only a mild phagocytic response, far below levels seen with the nonmucoid strains DLP and PAO-1. The difference seen in phagocytic response to the unopsonized nonmucoid revertant SRM-3R relative to the nonmucoid strains PAO-1 and DLP may be due to the presence of variable amounts of alginate on the cell surface of the nonmucoid revertant (26) , although the involvement of other cell surface components should not be ignored. The phagocytic response by NR8383 to the opsonized mucoid strain was still greatly reduced compared with the response to nonmucoid strains, implying that cell-associated alginate might inhibit opsonic phagocytosis. It has been reported previously, however, that an antibody to alginate from a P. aeruginosa strain mediated phagocytic killing by human PMN, suggesting that the antiphagocytic properties of alginate could be overcome by an alginate-specific antibody (1) . Previous studies reporting no differences in responses of macrophages to mucoid and nonmucoid strains of P. aeruginosa have most likely involved cultures of mixed phenotypes (5, 6, 31) .
It is well known that phagocytosis of microorganisms is accompanied by a dramatic increase in oxygen consumption and the elaboration of reactive oxygen species by the phagocyte (2, 4) . Luminol-enhanced CL and hydrogen peroxide assays were therefore used to determine the ability of mucoid and nonmucoid strains of P. aeruginosa to elicit an oxidative response from NR8383 and PMN. Luminol-enhanced CL assays, paralleling the phagocytic assays, revealed an inability of NR8383 and PMN to respond to the mucoid phenotype, while the nonmucoid strains elicited marked CL responses. Assays for the detection of H202 likewise revealed distinct differences between the abilities of mucoid and nonmucoid strains to elicit a response by alveolar macrophages. These results are similar to those of other studies (3, 34) , for which it was concluded that the mucoid exopolysaccharide (alginate) alters the surface characteristics of nonopsonized P. aeruginosa, rendering them resistant to phagocytosis by PMN and macrophages.
In response to reports that alginate inhibited phagocytosis of nonmucoid P. aeruginosa strains (34, 42, 43) , we initiated studies in which the nonmucoid strain PAO-1 was treated with extracellular alginate prior to macrophage challenge. Reported physiologic levels of alginate (33, 34) (15, 16) . This inhibition of phagocytosis by alginate did not occur in a dose-responsive manner, as has been seen previously (34) . The addition of a highly charged polysaccharide to these phagocytic systems in which sugars are directly involved in recognition is apparently complex. However, the inhibition of opsonic phagocytosis by alginate did raise the question of whether or not alginate was blocking opsonization of the bacteria or the interaction of opsonized bacteria with the phagocyte. Experiments designed to block either opsonization, phagocytosis of opsonized bacteria, or both indicated that alginate does not interfere with opsonization but does inhibit interaction of the phagocyte with bacteria that would lead to production of H202. Other reports dealing with the inhibitory effects of alginate on opsonization have revealed similar findings (3, 20) .
Results obtained in the CL and H202 assays using strain PAO-1 treated with purified bacterial alginate from strain SRM-3 suggest some nonspecific interaction of the alginate within the assays. The nonspecific fluorescing in the H202 assays cannot be explained by us at this time. The inhibition of CL response by bacterial alginate may be due to hypochlorite scavenging by the alginate, which has recently been reported (28) . In those studies, seaweed alginate was less effective at scavenging hypochlorite than was bacterial alginate, which may explain why we did not encounter this problem in our studies using commercial alginate. Scavenging of hypochlorite would have no effect on the H202 assays employed in our studies, since myeloperoxidase is not involved (unpublished observations). It is also unlikely that the lack of macrophage response seen in the H202 assays in the presence of bacterial alginate is due to contaminating lipopolysaccharide. Lipopolysaccharide could not be detected by assaying for 3-ketodeoxyoctonate by the thiobarbituric acid assay. Limulus assays were positive for both seaweed alginate and the bacterial alginate at levels that would have been detectable in the thiobarbituric acid assay. High concentrations of alginate nonspecifically gel in the Limulus assay (unpublished observation). It would be of considerable importance to determine the effect of bacterial alginate on the H202 and CL assay systems. Although it seems unlikely that 0.5 mg of bacterial alginate per ml would be more inhibitory to phagocytosis than 2 mg of seaweed alginate per ml, this possibility cannot be ruled out, since bacterial alginate differs from seaweed alginate in both chemical composition and molecular size (13, 32) .
We and other laboratories (7, 14, 29, 36) are intensely interested in the phenomenon of nonopsonic phagocytosis. This capability seems teleologically appropriate to the alveolar macrophage, considering its unique disposition at the environment/mucous interface. Indeed, it has been shown that AM, in contrast to PMN and freshly derived peripheral blood monocytes, can ingest glycoconjugates, such as are contained in many microbial cell walls (and zymosan), via mannose receptors (10, 14, 40) . Accordingly, we attempted to demonstrate an inhibitory effect of the zymosan and unopsonized P. aeruginosa-induced respiratory burst in NR8383 by D-mannose (Table 2 ). In contrast to other studies (8, 46) , we were unable to demonstrate D-mannose inhibition of H202 generation.
In contrast to what was shown above, some investigators have reported that PMN are also capable of nonopsonic phagocytosis (7, 8, 29) . This is in agreement with our own observations of a CL response to unopsonized P. aeruginosa in human PMN (Fig. 2) . While we cannot reconcile the fact that PMN have been reported to be devoid of mannose/ N-acetylglucosamine receptors (44) , it is clear that our own PMN preparations, as well as those of Danley and Hilger (8) , contained a contaminating population of monocytes, which could provide products of the classical and alternative complement pathways to be deposited locally on otherwise unopsonized particles (14) . Still another potential mechanism has been addressed by Lee and co-workers (29) , in which adherent organisms were phagocytized and induced CL in the absence of exogenous opsonins. Observations during our own studies consistently revealed a lack of background adherence by the mucoid strain, while the nonmucoid forms, which were ingested by phagocytes, adhered to glass cover slips.
There are probably many bacterial and nonbacterial factors which affect attachment phenomena and interfere with bacterium-phagocyte interactions. Such factors on the surface of P. aeruginosa other than alginate could include pili and smooth or rough lipopolysaccharide. Although the chronic lung disease in cystic fibrosis patients involves a complex series of host-parasite interactions, the role of the alginic acid polysaccharide produced by the mucoid strains of P. aeruginosa in inhibiting phagocytic response to the bacteria is evident.
